AFFINITY WEALTH LLC’s Pyxis Oncology PYXS Stock Holding History

AFFINITY WEALTH LLC’s Portfolio PYXS Stock Details PYXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,400	Closed	-$1.37K	–	75
2025 Q1	$1.37K	Buy	+1,400	New	+$1.87K	﹤0.01%	35

Other funds holding PYXS

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AFFINITY WEALTH LLC's PYXS Position: Q2 2025 in Review

AFFINITY WEALTH LLC sold out of Pyxis Oncology (PYXS) in Q2 2025, closing a stake of 1,400 shares — an estimated $1.37K sold.

AFFINITY WEALTH LLC first reported a position in PYXS in Q1 2025 and held it in 1 quarter. The position peaked at $1.37K in Q1 2025. 74 funds tracked by Wall St. Rank hold PYXS as of Q2 2025.

AFFINITY WEALTH LLC reported no remaining Pyxis Oncology position as of Q2 2025 after selling out during the quarter.
AFFINITY WEALTH LLC sold 1,400 Pyxis Oncology shares in Q2 2025, an estimated $1.37K.
AFFINITY WEALTH LLC first reported a position in Pyxis Oncology in Q1 2025 and held it in 1 quarter.
AFFINITY WEALTH LLC's Pyxis Oncology position peaked at $1.37K in Q1 2025.
74 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2025.

Based on AFFINITY WEALTH LLC's 13F filing for Q2 2025, filed 26 Aug 2026.